Stryker Corp (SYK)
390.14
+4.46
(+1.16%)
USD |
NYSE |
Nov 21, 16:00
390.07
-0.07
(-0.02%)
After-Hours: 20:00
Stryker Enterprise Value: 159.53B for Nov. 21, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 21, 2024 | 159.53B |
| November 20, 2024 | 157.83B |
| November 19, 2024 | 158.97B |
| November 18, 2024 | 159.25B |
| November 15, 2024 | 159.50B |
| November 14, 2024 | 156.91B |
| November 13, 2024 | 158.84B |
| November 12, 2024 | 158.37B |
| November 11, 2024 | 155.23B |
| November 08, 2024 | 154.12B |
| November 07, 2024 | 151.79B |
| November 06, 2024 | 151.48B |
| November 05, 2024 | 151.80B |
| November 04, 2024 | 150.67B |
| November 01, 2024 | 150.76B |
| October 31, 2024 | 146.62B |
| October 30, 2024 | 149.35B |
| October 29, 2024 | 147.66B |
| October 28, 2024 | 146.52B |
| October 25, 2024 | 145.30B |
| October 24, 2024 | 148.00B |
| October 23, 2024 | 149.27B |
| October 22, 2024 | 150.33B |
| October 21, 2024 | 150.80B |
| October 18, 2024 | 151.68B |
| Date | Value |
|---|---|
| October 17, 2024 | 147.93B |
| October 16, 2024 | 148.54B |
| October 15, 2024 | 147.65B |
| October 14, 2024 | 147.93B |
| October 11, 2024 | 146.36B |
| October 10, 2024 | 145.51B |
| October 09, 2024 | 145.74B |
| October 08, 2024 | 144.53B |
| October 07, 2024 | 142.37B |
| October 04, 2024 | 144.69B |
| October 03, 2024 | 144.84B |
| October 02, 2024 | 146.17B |
| October 01, 2024 | 147.00B |
| September 30, 2024 | 148.52B |
| September 27, 2024 | 147.56B |
| September 26, 2024 | 147.97B |
| September 25, 2024 | 147.26B |
| September 24, 2024 | 147.83B |
| September 23, 2024 | 149.94B |
| September 20, 2024 | 149.29B |
| September 19, 2024 | 149.38B |
| September 18, 2024 | 147.97B |
| September 17, 2024 | 148.96B |
| September 16, 2024 | 152.01B |
| September 13, 2024 | 151.36B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
54.08B
Minimum
Mar 23 2020
159.53B
Maximum
Nov 21 2024
108.28B
Average
107.97B
Median
Jan 24 2023
Enterprise Value Benchmarks
| Boston Scientific Corp | 143.48B |
| Globus Medical Inc | 11.30B |
| Zimmer Biomet Holdings Inc | 27.59B |
| Baxter International Inc | 28.43B |
| Treace Medical Concepts Inc | 465.07M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 834.00M |
| Revenue (Quarterly) | 5.494B |
| Total Expenses (Quarterly) | 4.409B |
| EPS Diluted (Quarterly) | 2.16 |
| Gross Profit Margin (Quarterly) | 64.02% |
| Profit Margin (Quarterly) | 15.18% |
| Earnings Yield | 2.39% |
| Operating Earnings Yield | 2.92% |
| Normalized Earnings Yield | 2.391 |